Our data also indicate that 3 μg/kg VT treatment in T1DM stroke rats significantly increases MBP(p < 0.001, Figure 2B), decreases SMI‐32 (p < 0.01, Figure 2C), and decreases SMI‐32/MBP ratio (p < 0.01, Figure 2D) in the IBZ compared to PBS‐treated T1DM stroke rats. This evidence concerns the gene MBP and type 1 diabetes mellitus.